Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn P T Ernst

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Iscience|January 6, 2020
Sharpening the Molecular Scissors: Advances in Gene-Editing TechnologyMike Broeders, Pablo Herrero-Hernandez, Martijn P T Ernst, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human DiseaseMartijn P T Ernst, Mike Broeders, Pablo Herrero-Hernandez, et al.
Pediatric Blood & Cancer|November 1, 2022
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factorJacqueline Feyen, Martijn P T Ernst, Vincent H J van der Velden, et al.
Hemasphere|February 6, 2023
Hematopoietic Cell Autonomous Disruption of Hematopoiesis in a Germline Loss-of-function Mouse Model of <i>RUNX1</i>-FPDMartijn P T Ernst, Eline Pronk, Claire van Dijk, et al.
Blood Advances|January 13, 2022
Validation and clinical application of transactivation assays for RUNX1 variant classificationMelanie Decker, Anupriya Agarwal, Andreas Benneche, et al.
Hemasphere|January 17, 2025
Disease characteristics and outcomes of acute myeloid leukemia in germline <i>RUNX1</i> deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)Martijn P T Ernst, Jurjen Versluis, Peter J M Valk, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Iscience|January 6, 2020
Sharpening the Molecular Scissors: Advances in Gene-Editing TechnologyMike Broeders, Pablo Herrero-Hernandez, Martijn P T Ernst, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human DiseaseMartijn P T Ernst, Mike Broeders, Pablo Herrero-Hernandez, et al.
Pediatric Blood & Cancer|November 1, 2022
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factorJacqueline Feyen, Martijn P T Ernst, Vincent H J van der Velden, et al.
Hemasphere|February 6, 2023
Hematopoietic Cell Autonomous Disruption of Hematopoiesis in a Germline Loss-of-function Mouse Model of <i>RUNX1</i>-FPDMartijn P T Ernst, Eline Pronk, Claire van Dijk, et al.
Blood Advances|January 13, 2022
Validation and clinical application of transactivation assays for RUNX1 variant classificationMelanie Decker, Anupriya Agarwal, Andreas Benneche, et al.
Hemasphere|January 17, 2025
Disease characteristics and outcomes of acute myeloid leukemia in germline <i>RUNX1</i> deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)Martijn P T Ernst, Jurjen Versluis, Peter J M Valk, et al.
Pageof 1